BOX vs REGN · P/E 26, rev $1.09B vs P/E 14, rev $14.34B
Box Inc (BOX) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Box Inc (BOX) is a software - infrastructure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BOX revenue for 2025-01-31 was $1.09B. Net income was $244.6M. Revenue was up 5.0% from 2024-01-31 to 2025-01-31. BOX currently screens at market cap $4.95B and trailing P/E 26.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BOX currently screens at market cap $4.95B and trailing P/E 26.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BOX and REGN stock pages for the full models.
Not investment advice.